Lindy Biosciences
Biotechnology, Product Research, Therapeutics
Founded in 1/1/17
Durham, North Carolina, United States
For Profit
About Lindy Biosciences
Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 6646236 USD
- Last Funding: 3200000 USD (Series B)
- Funding Status: Early Stage Venture
Technology Stack
Lindy Biosciences actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Product Research, Therapeutics
Headquarters: Durham, North Carolina, United States